Abstract
Tumor-targeted nanoparticle delivery system has been known as a substitute and capable achievement in cancer treatment compared to conventional methods. In this study, we examined potential application of ɑ-tocotrienol-Precirol formulation to enhance efficiency of doxorubicin (DOX) in induction of apoptosis in HUH-7 hepatocarcinoma cells. ɑ-tocotrienol-loaded nanoparticles were characterized at the point of zeta potential, particle size, scanning electron microscope (SEM), and cell internalization. To evaluate antiproliferative effects of formulation, apoptosis, cell cycle procedure, flow cytometry, and MTT assays were employed. Optimum size of the ɑ-tocotrienol formulation revealed narrow size distribution with mean average of 78 ± 3 nm. IC50 values for ɑ-tocotrienol and ɑ-tocotrienol-nano structured lipid carriers after 24 h were 15 ± 0.6 and 10 ± 0.03 µM, respectively. After incubation of cells with ɑ-tocotrienol-loaded careers, the rate of cell proliferation decreased from 53 ± 6.1 to 34 ± 7.1% (P < 0.05). A significant improvement in the apoptosis percentage was revealed after treatment of the HUH-7 cell line with DOX and ɑ-tocotrienol careers (P < 0.05). Gene expression results demonstrated a marked decrease in survivin a...Continue Reading
References
Oct 2, 1992·Journal of Medicinal Chemistry·B C PearceJ J Wright
Apr 11, 2000·Lipids·B S McIntyreP W Sylvester
Jun 24, 2003·International Journal of Pharmaceutics·Jamila HamdaniKarim Amighi
Dec 31, 2003·Biochemical Pharmacology·Keiko Takahashi, George Loo
May 13, 2005·Journal of Ethnopharmacology·C C Lee, Peter Houghton
Jun 10, 2006·Biochemical and Biophysical Research Communications·Janmejai K Srivastava, Sanjay Gupta
Sep 1, 2006·Journal of the American College of Nutrition·Marion DietrichGladys Block
Mar 30, 2007·Lipids·Wakako TsuzukiHiroyuki Yoshimura
Nov 29, 2007·Biochemical and Biophysical Research Communications·Korehito KashiwagiTomohiro Yano
Oct 15, 2008·Biomaterials·Zhenghong XuYaping Li
Feb 17, 2010·Breast Cancer Research and Treatment·Sook Kyung ParkKimberly Kline
Feb 18, 2012·Journal of Pineal Research·Jingshu WangWuguo Deng
Jun 6, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Surajit DasReginald B H Tan
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
May 27, 2014·PloS One·Eveline A I F QueirozNeelam Khaper
Dec 2, 2014·Nutrition & Metabolism·Haseeb AhsanWaseem A Siddiqui
Dec 3, 2014·International Journal of Pharmaceutics·Antonio LeonardiRosario Pignatello
Dec 7, 2014·BMC Complementary and Alternative Medicine·Su-Wen LimNazariah A Zeenathul
Sep 8, 2015·Current Drug Targets·Marco MalavoltaMauro Provinciali
Dec 15, 2015·Nanomedicine·Vahid Heravi SharghMingtao Liang
Dec 27, 2015·Pharmacology & Therapeutics·Hong Yong PehW S Fred Wong
Jan 11, 2016·Molecular Biology Reports·Akbar MinaeiNasser Samadi
Mar 8, 2016·BioFactors·Leanne De SilvaJu-Yen Fu
Apr 2, 2016·Research in Veterinary Science·Jinjin TongYun Liu
Oct 18, 2016·Drug Delivery·Hong JiangJing Cao
Nov 28, 2016·The Journal of Nutritional Biochemistry·Ying HuangAh-Ng Kong
Aug 10, 2017·Drug Discovery Today·Madhu M KanchiAlan P Kumar
Jan 10, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Hamed HajipourRamezan Ali Taheri
Citations
Feb 6, 2021·Hormone Molecular Biology and Clinical Investigation·Pirouz PourmohammadYavar Mahmoodzadeh
Jan 23, 2020·Hormone Molecular Biology and Clinical Investigation·Vahid VahedianNazila Fathi Maroufi
Mar 19, 2021·Naunyn-Schmiedeberg's Archives of Pharmacology·Shahram AhmadianHossain Bijanpour
Jul 3, 2021·Nutrients·Jessica MaiuoloVincenzo Mollace
Oct 1, 2021·Naunyn-Schmiedeberg's Archives of Pharmacology·Mehdi SabzichiFatemeh Ramezani